PERSONAL Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.
Over the past two decades, synergistic innovations in imaging technology have resulted in a revolution in which a range of biomedical applications are now benefiting from fluorescence imaging. Fluorescence imaging of lymph nodes after systemic cetuximab-IRDye800CW administration demonstrated high sensitivity and was capable of identifying additional positive nodes on deep sectioning.
Eben L. Rosenthal M.D.,Nynke van den Berg,Tarn Teraphongphom, andJason Warram
"Clinical trial results using fluorescently labeled antibodies (Conference Presentation)", Proc. SPIE 10469, Optical Imaging, Therapeutics, and Advanced Technology in Head and Neck Surgery and Otolaryngology 2018, 104690E (14 March 2018); https://doi.org/10.1117/12.2297305
ACCESS THE FULL ARTICLE
INSTITUTIONAL Select your institution to access the SPIE Digital Library.
PERSONAL Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.
The alert did not successfully save. Please try again later.
Eben L. Rosenthal M.D., Nynke van den Berg, Tarn Teraphongphom, Jason Warram, "Clinical trial results using fluorescently labeled antibodies (Conference Presentation)," Proc. SPIE 10469, Optical Imaging, Therapeutics, and Advanced Technology in Head and Neck Surgery and Otolaryngology 2018, 104690E (14 March 2018); https://doi.org/10.1117/12.2297305